Loading…
Prevest Denpro (BSE 543363)₹418.15+5.10%Medical Equipment & Supplies
In the Jun 2026 quarter (consolidated), Prevest Denpro reported sales of ₹19.09 Cr, up 20.9% from Jun 2025, and net profit of ₹5.65 Cr, up 27.8% year on year. For the year to Mar 2026, sales were ₹72.07 Cr and net profit ₹19.99 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.19 | 13.63 | 16.26 | 13.37 | 16.28 | 14.98 | 18.46 | 15.79 | 18.67 | 18.48 | 18.96 | 19.09 |
| Expenses | 8.78 | 9.13 | 10.23 | 8.83 | 10.45 | 9.75 | 11.92 | 10.45 | 11.95 | 12.65 | 12.02 | 12.30 |
| Operating Profit | 4.40 | 4.47 | 5.99 | 4.51 | 5.80 | 5.20 | 6.55 | 5.30 | 6.67 | 5.79 | 6.90 | 6.75 |
| OPM % | 33.4% | 32.8% | 36.9% | 33.8% | 35.6% | 34.8% | 35.4% | 33.6% | 35.8% | 31.3% | 36.4% | 35.4% |
| Other Income | 0.73 | 0.67 | 0.83 | 0.85 | 1.03 | 1.08 | 1.07 | 1.16 | 1.18 | 1.14 | 1.40 | 1.31 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.23 | 0.43 | 0.47 | 0.49 | 0.46 | 0.49 | 0.46 | 0.50 | 0.51 | 0.52 | 0.52 | 0.53 |
| Profit before tax | 4.94 | 4.75 | 6.39 | 4.91 | 6.39 | 5.83 | 7.16 | 6.00 | 7.38 | 6.45 | 7.82 | 7.57 |
| Tax % | 26.2% | 23.3% | 25.1% | 25.1% | 24.7% | 22.2% | 28.2% | 26.4% | 24.8% | 26.7% | 25.5% | 25.4% |
| Net Profit | 3.65 | 3.63 | 4.78 | 3.66 | 4.81 | 4.54 | 5.13 | 4.42 | 5.55 | 4.73 | 5.81 | 5.65 |
| EPS (Rs) | 3.02 | 3.02 | 3.96 | 3.05 | 4.00 | 3.76 | 4.26 | 3.66 | 4.60 | 3.91 | 4.83 | 4.68 |
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| Sales | 56.07 | 63.03 | 72.07 | 75.20 |
| Expenses | 35.96 | 41.02 | 46.98 | 48.92 |
| Operating Profit | 19.97 | 22.01 | 24.98 | 26.11 |
| OPM % | 35.9% | 34.9% | 34.9% | 34.7% |
| Other Income | 2.99 | 3.99 | 4.98 | 5.03 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.01 | 1.99 | 2.01 | 2.08 |
| Profit before tax | 21.03 | 24.03 | 28.03 | 29.22 |
| Tax % | 25.0% | 25.1% | 26.0% | — |
| Net Profit | 16.01 | 17.99 | 19.99 | 21.74 |
| EPS (Rs) | 13.41 | 15.08 | 17.01 | 18.02 |
| Dividend payout % | 7.0% | 7.0% | 0.0% | — |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 12.04 | 12.03 | 12.04 |
| Reserves | 77.00 | 94.02 | 113 |
| Borrowings | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 6.03 | 7.04 | 8.04 |
| Total Liabilities | 95.07 | 113 | 133 |
| Fixed Assets | 26.90 | 26.90 | 26.93 |
| CWIP | 0.00 | 0.00 | 0.00 |
| Investments | 1.99 | 4.99 | 8.99 |
| Other Assets | 66.18 | 81.20 | 98.24 |
| Inventories | 6.01 | 8.01 | 11.01 |
| Trade receivables | 7.97 | 7.97 | 8.97 |
| Cash & equivalents | 49.11 | 61.09 | 73.16 |
| Total Assets | 95.07 | 113 | 133 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from operating activity | 11.99 | 14.99 | 14.99 |
| Cash from investing activity | −2.01 | −1.01 | −2.01 |
| Cash from financing activity | 0.00 | −0.99 | −0.99 |
| Net cash flow | 10.02 | 12.03 | 12.03 |
| Capex | 3.74 | 1.98 | 1.90 |
| Free cash flow | 7.99 | 12.98 | 12.97 |
| CFO / OP % | 81.1% | 93.1% | 86.0% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor days | 53 | 44 | 44 |
| Inventory days | 168 | 214 | 239 |
| Days payable | 32 | 43 | 55 |
| Cash conversion cycle | 190 | 216 | 230 |
| Working capital days | 80 | 83 | 92 |
| ROCE % | — | 25.0% | 24.0% |
For the Jun 2026 quarter, Prevest Denpro reported sales of ₹19.09 Cr, up 20.9% year on year and net profit of ₹5.65 Cr, up 27.8% year on year. The operating margin was 35.4%.
Prevest Denpro's sales for the year to Mar 2026 were ₹72.07 Cr; over the last twelve months they were ₹75.20 Cr.
Net profit for the year to Mar 2026 was ₹19.99 Cr, and ₹21.74 Cr over the last twelve months. Earnings per share over the same trailing period were ₹18.02.
Prevest Denpro reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹73.16 Cr.
Cash from operations was ₹14.99 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹12.97 Cr.